Sitagliptin recalls
The FDA has published 2 recalls involving Sitagliptin since 2014. The latest was reported on 13 Apr 2022. Most were for packaging defects. Merck Sharp & Dohme has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 13 Apr 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why sitagliptin is recalled
Companies
By year
All sitagliptin recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Janumet (sitagliptin and metformin HCl) tablets recalledJanumet | Merck Sharp & Dohme | Particulate Matter | Nationwide |
| Drug | CLASS II | sitaGLIPtin Phosphate, Tablet, 50 mg recalled by Aidapak Services | Aidapak Services | Packaging Defects | 4 states |
Should you stop taking Sitagliptin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.